These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 10968690

  • 1. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG, Schiff M, Graves B, Agosti J, Barritt ML, Garner D, Holley JL.
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
    Sali S, Alavian SM, Hajarizadeh B.
    Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure--results of a prospective, randomized trial.
    Singh NP, Mandal SK, Thakur A, Kapoor D, Anuradha S, Prakash A, Kohli R, Agarwal SK.
    Ren Fail; 2003 Mar; 25(2):255-66. PubMed ID: 12739832
    [Abstract] [Full Text] [Related]

  • 8. Effect of granulocyte macrophage colony stimulating factor on hepatitis-B vaccination in haemodialysis patients.
    Sudhagar K, Chandrasekar S, Rao MS, Ravichandran R.
    J Assoc Physicians India; 1999 Jun; 47(6):602-4. PubMed ID: 10999156
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [Abstract] [Full Text] [Related]

  • 13. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A, Zarei S, Shokri F.
    Vaccine; 2008 Jan 10; 26(2):269-76. PubMed ID: 18037544
    [Abstract] [Full Text] [Related]

  • 14. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
    Tung J, Carlisle E, Smieja M, Kim PT, Lee CH.
    Am J Kidney Dis; 2010 Oct 10; 56(4):713-9. PubMed ID: 20630640
    [Abstract] [Full Text] [Related]

  • 15. Seroprotection after hepatitis B vaccination in chronic kidney disease patients with modified schedule and dosage.
    Siddiqui S, Malik A, Shukla I, Rizvi M, Haque SF.
    J Infect Dev Ctries; 2010 Jun 30; 4(6):389-92. PubMed ID: 20601791
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
    Alavian SM, Tabatabaei SV.
    Clin Ther; 2010 Jan 30; 32(1):1-10. PubMed ID: 20171406
    [Abstract] [Full Text] [Related]

  • 19. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD, Mashinter LD, Lindemulder A, Taylor GD, Chiu I.
    HIV Med; 2007 Jul 30; 8(5):295-9. PubMed ID: 17561875
    [Abstract] [Full Text] [Related]

  • 20. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients.
    Verkade MA, van de Wetering J, Klepper M, Vaessen LM, Weimar W, Betjes MG.
    Kidney Int; 2004 Aug 30; 66(2):614-21. PubMed ID: 15253714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.